A detailed history of Alphabet Inc. transactions in Kronos Bio, Inc. stock. As of the latest transaction made, Alphabet Inc. holds 1,438,232 shares of KRON stock, worth $1.24 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
1,438,232
Previous 1,438,232 -0.0%
Holding current value
$1.24 Million
Previous $1.78 Million 19.35%
% of portfolio
0.1%
Previous 0.11%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Nov 14, 2022

BUY
$26.68 - $38.23 $38.4 Million - $55 Million
1,438,232 New
1,438,232 $43 Million

Others Institutions Holding KRON

About Kronos Bio, Inc.


  • Ticker KRON
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,769,100
  • Market Cap $48.8M
  • Description
  • Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib (ENTO), is an orally...
More about KRON
Track This Portfolio

Track Alphabet Inc. Portfolio

Follow Alphabet Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alphabet Inc., based on Form 13F filings with the SEC.

News

Stay updated on Alphabet Inc. with notifications on news.